CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program

NEXT STORY
Galera Therapeutics Announces New Data from the Phase 2b Trial on the Effect of Avasopasem Manganese on Cisplatin-Induced Chronic Kidney Disease to be Presented at ASCO 2020 Virtual Scientific Program
PREV STORY
SEngine Precision Medicine to Present Data Related to the Predictive Value of the PARIS® Test for Oncology Drugs Based on Retrospective Analysis at 2020 ASCO Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EUROBIO SCIENTIFIC CERTIFIED ISO 13485 V2016

EUROBIO SCIENTIFIC CERTIFIED ISO 13485 V2016 Eurobio Scientific has successfully upgraded its quality management ...

author_avatar
NASDAQ Market News

Orion Group Financial Statement documents 2016 and Corporate Governance Statement published

ORION CORPORATION         STOCK EXCHANGE RELEASE 27 FEBRUARY 2017 at 13.00 EET                       Orion Group ...

author_avatar
NASDAQ Market News

Immunotech Laboratories, Inc. Enters Negotiations to Engage a Quality Person (QP) for Receipt and Distribution of Treatment in Europe

MONROVIA, CA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Immunotech Laboratories, Inc. (OTC Markets "ECPO", ...

author_avatar
NASDAQ Market News